BDBM403253 US10329303, Example 52

SMILES CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cc(NCNC(=O)C(N)CCC(N)=O)nc4ccccc34)cc12

InChI Key InChIKey=UANXWJKQUVXWSW-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 403253   

TargetMalignant T-cell-amplified sequence 1(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM403253(US10329303, Example 52)
Affinity DataEC50: <20nMAssay Description:pecific Examples 1-52 of compounds of the invention, with estimated EC50 values determined using an MTT assay for 4-day viability of Raji (Burkitt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
Go to US Patent